169 results
Page 6 of 9
8-K
EX-10.1
wu95v
18 Jan 19
Departure of Directors or Certain Officers
4:06pm
8-K
EX-99.1
ktqj7phvs
7 Jan 19
Regulation FD Disclosure
8:26am
8-K
EX-99.1
l860oh8 1c2x25wh5
8 Nov 18
Karyopharm Reports Third Quarter 2018 Financial Results and Highlights Recent Company Progress
7:08am
424B5
pkqt0v tmh92g
17 Aug 18
Prospectus supplement for primary offering
4:05pm
8-K
EX-10.1
88eqcuf8rzbhlr7i6g
17 Aug 18
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
qygyv79 22skf
7 Aug 18
Karyopharm Reports Second Quarter 2018 Financial Results and Highlights Recent Progress
7:18am
8-K
EX-99.1
tm6c0 1swqiem5toxn
6 Aug 18
Other Events
4:17pm
8-K
EX-99.1
ldja 4pav
20 Jun 18
Regulation FD Disclosure
7:01am
8-K
EX-99.1
7ihdz5bezcfhggkjuiz
7 Jun 18
Regulation FD Disclosure
7:00am
8-K
EX-99.1
s2l0leii910u5qa3va
10 May 18
Karyopharm Reports First Quarter 2018 Financial Results and Highlights Recent Progress
7:11am
8-K
EX-1.1
91krvg v5gn3d11ugv
3 May 18
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
5:02pm
424B5
epknbqogbz00wxe3l
3 May 18
Prospectus supplement for primary offering
5:00pm